Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Collaborative Groups / Breast and Gynecologic Cancers Research Group / The Risk of Ovarian Malignancy Algorithm (ROMA) algorithm was approved by the FDA in 2011

The Risk of Ovarian Malignancy Algorithm (ROMA) algorithm was approved by the FDA in 2011

Click here to view more information about ROMA in the biomarker database.

2016 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take on a date and location to be determined.